Crypto News | Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug Liam ‘Akiba’ Wright | usagoldmines.com
Enlivex, a Nasdaq-listed biotechnology company, is asking shareholders to authorize up to $800 million of...